Nothing Special   »   [go: up one dir, main page]

Beckers et al., 2024 - Google Patents

Microbiome and pregnancy: focus on microbial dysbiosis coupled with maternal obesity

Beckers et al., 2024

View HTML
Document ID
1689457535751435303
Author
Beckers K
Flanagan J
Sones J
Publication year
Publication venue
International Journal of Obesity

External Links

Snippet

Obesity is becoming a worldwide pandemic with over one billion people affected. Of women in the United States, who are of childbearing age, two-thirds of them are considered overweight/obese. Offspring of women with obesity have a greater likelihood of developing …
Continue reading at www.nature.com (HTML) (other versions)

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay
    • G01N33/569Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911Bacteria
    • G01N33/56916Enterobacteria, e.g. shigella, salmonella, klebsiella, serratia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Micro-organisms or materials therefrom
    • A61K35/74Bacteria
    • A61K35/741Probiotics
    • A61K35/744Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745Bifidobacteria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Micro-organisms or materials therefrom
    • A61K35/74Bacteria
    • A61K35/741Probiotics
    • A61K35/744Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747Lactobacilli, e.g. L. acidophilus or L. brevis
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Hybridisation probes
    • C12Q1/6883Hybridisation probes for diseases caused by alterations of genetic material

Similar Documents

Publication Publication Date Title
Durack et al. Delayed gut microbiota development in high-risk for asthma infants is temporarily modifiable by Lactobacillus supplementation
Khalili et al. The role of diet in the aetiopathogenesis of inflammatory bowel disease
Šuligoj et al. Effects of human milk oligosaccharides on the adult gut microbiota and barrier function
Da Silva et al. Nonalcoholic fatty liver disease is associated with dysbiosis independent of body mass index and insulin resistance
Sanctuary et al. Pilot study of probiotic/colostrum supplementation on gut function in children with autism and gastrointestinal symptoms
Charbonneau et al. A microbial perspective of human developmental biology
Mokkala et al. Metagenomics analysis of gut microbiota in response to diet intervention and gestational diabetes in overweight and obese women: a randomised, double-blind, placebo-controlled clinical trial
Rodríguez et al. The composition of the gut microbiota throughout life, with an emphasis on early life
Walker et al. The prenatal gut microbiome: are we colonized with bacteria in utero?
Scheepers et al. The intestinal microbiota composition and weight development in children: the KOALA Birth Cohort Study
Kerr et al. Early life events influence whole-of-life metabolic health via gut microflora and gut permeability
Gohir et al. Of the bugs that shape us: maternal obesity, the gut microbiome, and long-term disease risk
Ainonen et al. Antibiotics at birth and later antibiotic courses: effects on gut microbiota
Dotterud et al. Probiotics in pregnant women to prevent allergic disease: a randomized, double‐blind trial
Prince et al. The microbiome and development: a mother's perspective
Rutayisire et al. Cesarean section may increase the risk of both overweight and obesity in preschool children
Al Rubaye et al. The role of maternal diet on offspring gut microbiota development: A review
Galipeau et al. Gut microbes and adverse food reactions: Focus on gluten related disorders
Zachariassen et al. Cesarean section induces microbiota-regulated immune disturbances in C57BL/6 mice
Lemaire et al. Addition of dairy lipids and probiotic Lactobacillus fermentum in infant formula programs gut microbiota and entero-insular axis in adult minipigs
Azagra-Boronat et al. Lactobacillus fermentum CECT5716 supplementation in rats during pregnancy and lactation impacts maternal and offspring lipid profile, immune system and microbiota
Hiltunen et al. Spontaneous preterm delivery is reflected in both early neonatal and maternal gut microbiota
Wolf et al. Gut microbiota and obesity
Werlang et al. Associations of birth mode with cord blood cytokines, white blood cells, and newborn intestinal bifidobacteria
Vacca et al. The establishment of the gut microbiota in 1-year-aged infants: from birth to family food